ADAPTIMMUNE THERAPEUTICS PLC Debt Securities, Available-for-sale, Realized Loss
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Debt Securities, Available-for-sale, Realized Loss of $0 for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-06.
Discontinued › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss · last filed 2021-02-25
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized loss for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized loss for the quarter ending 2018-12-31 was -$4.95M.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized loss for the quarter ending 2018-09-30 was $0.00.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized loss for the quarter ending 2018-06-30 was $1.31M.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized loss for fiscal 2018 was -$2.47M, a 482.82% decline from fiscal 2017.
- ADAPTIMMUNE THERAPEUTICS PLC debt securities, available-for-sale, realized loss for fiscal 2017 was $646.00K.
| Period end | Debt Securities, Available-for-sale, Realized Loss 3 month | Debt Securities, Available-for-sale, Realized Loss 6 month | Debt Securities, Available-for-sale, Realized Loss 9 month | Debt Securities, Available-for-sale, Realized Loss 12 month | Debt Securities, Available-for-sale, Realized Loss 12 month as first filed |
|---|---|---|---|---|---|
| 2019-03-31 | $0.00 10-Q · filed 2019-05-06 | -$4.95M derived: sum of 2 quarters · filed 2021-02-25 | -$4.95M derived: sum of 3 quarters · filed 2021-02-25 | -$3.64M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$4.95M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$4.95M derived: sum of 2 quarters · filed 2021-02-25 | -$3.64M derived: sum of 3 quarters · filed 2021-02-25 | -$2.47M 10-K · filed 2021-02-25 | $2.47M 10-K · filed 2019-02-27 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-06 | $1.31M derived: sum of 2 quarters · filed 2019-08-01 | $2.47M 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $1.31M 10-Q · filed 2019-08-01 | $2.47M 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $1.16M 10-Q · filed 2019-05-06 | ||||
| 2017-12-31 | $646.00K 10-K · filed 2019-02-27 |